Verve Therapeutics (VERV) Earnings Date, Estimates & Call Transcripts $4.79 -0.59 (-10.97%) (As of 11/15/2024 08:55 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 25EstimatedActual EPS (Nov. 5) -$0.59 Beat By $0.11 Consensus EPS (Nov. 5) -$0.70 Verve Therapeutics posted Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.59, which beat analysts' consensus estimates of -$0.70 by $0.11. Quarterly revenue rose 120.2% year-over-year to $6.87 million, above analyst estimates of $2.75 million. With a trailing EPS of -$2.46, Verve Therapeutics' earnings are expected to decrease next year, from ($2.49) to ($2.91) per share. VERV Upcoming EarningsVerve Therapeutics' next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules. Skip Charts & View Estimated and Actual Earnings DataVERV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VERV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …And one special coin could do even better. Verve Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.79-$0.56-$0.68Q2 20242-$0.63-$0.58-$0.61Q3 20243-$0.72-$0.63-$0.67Q4 20243-$0.72-$0.55-$0.62FY 202410-$2.86-$2.32-$2.57Q1 20252-$0.66-$0.60-$0.63Q2 20252-$0.63-$0.63-$0.63Q3 20252-$0.67-$0.65-$0.66Q4 20252-$0.67-$0.66-$0.67FY 20258($2.63)($2.54)($2.59) Verve Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/25/2025(Estimated)------- 11/5/2024Q3 2024-$0.70-$0.59+$0.11-$0.59$2.75M$6.87M8/8/2024Q2 2024-$0.68-$0.59+$0.09-$0.59$2.40M$6.70M 5/8/2024Q1 2024-$0.70-$0.59+$0.11-$0.59$2.11M$5.70M 2/27/2024Q4 2023-$0.83-$0.69+$0.14-$0.69$3.95M$5.14M 11/7/2023Q3 2023-$0.90-$0.72+$0.18-$0.72$0.96M$3.10M 8/10/2023Q2 2023-$0.90-$0.87+$0.03-$0.87$0.67M$2.10M Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover5/15/2023Q1 2023-$0.77-$0.84 -$0.07-$0.84$1.00M$1.40M 3/2/2023Q4 2022-$0.76-$0.67+$0.09-$0.67$1.50M$1.01M Verve Therapeutics Earnings - Frequently Asked Questions When is Verve Therapeutics's earnings date? Verve Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on VERV's earnings history. Did Verve Therapeutics beat their earnings estimates last quarter? In the previous quarter, Verve Therapeutics (NASDAQ:VERV) reported ($0.59) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.70) by $0.11. Learn more on analysts' earnings estimate vs. VERV's actual earnings. How much revenue does Verve Therapeutics generate each year? Verve Therapeutics (NASDAQ:VERV) has a recorded annual revenue of $11.76 million. How much profit does Verve Therapeutics generate each year? Verve Therapeutics (NASDAQ:VERV) has a recorded net income of -$200.07 million. VERV has generated -$2.46 earnings per share over the last four quarters. What is Verve Therapeutics's EPS forecast for next year? Verve Therapeutics's earnings are expected to decrease from ($2.49) per share to ($2.91) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Scholar Rock Earnings Recursion Pharmaceuticals Earnings Mirum Pharmaceuticals Earnings Harmony Biosciences Earnings Wave Life Sciences Earnings Centessa Pharmaceuticals Earnings Nurix Therapeutics Earnings Disc Medicine Earnings Spyre Therapeutics Earnings Tarsus Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors Crypto’s next big bull run? (Ad)Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …And one special coin could do even better. This page (NASDAQ:VERV) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Verve Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
